Medtronic PLC only finalized its purchase of ventricular assist device innovator HeartWare International Inc. on Aug. 23, but the company has already added two more high-risk class I voluntary recalls to an ongoing series of reported issues with HeartWare's devices.
The device giant announced the class I designation of the recalls, which affect HeartWare’s HVAD System and HVAD Pump Implant Kits, on Sept. 30.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?